Clinical Trials Logo
  1. Home
  2. Persistent Atrial Fibrillation
  3. NCT05065112
  4. Details
NCT05065112 Clinical Trial

Individualised Mapping in Persistent AF Ablation

Persistent Atrial Fibrillation Clinical Trial

— IMAGE AF  

Official title:
Individualised MApping-Guided Ablation to Improve Outcomes in pErsistent Atrial Fibrillation

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05065112
Other study ID # 297733
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 2021
Est. completion date May 2025

Study information
Verified date September 2021
Source Royal Brompton & Harefield NHS Foundation Trust
Contact Vias Markides, MD, FESC
Phone 020 7352 8121
Email v.markides@imperial.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A clinical randomised trial to compare strategies for ablation in persistent and long-standing persistent atrial fibrillation comprising of two arms: pulmonary veins isolation (PVI) only and PVI + individualised mapping-guided ablation (Cartofinder, Biosense Webster Inc.)

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 212
Est. completion date May 2025
Est. primary completion date November 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age > 18 years old 2. Signed informed consent. 3. Scheduled to undergo a clinically indicated, first-time catheter ablation procedure for the treatment of persistent atrial fibrillation. 4. In atrial fibrillation at the time of the index procedure. Exclusion Criteria: 1. Paroxysmal atrial fibrillation. 2. Previous ablation procedure for atrial fibrillation. 3. Left ventricular ejection fraction < 45% 4. Obesity with BMI > 35 kg/m2 5. Congenital heart disease. 6. Previous cardiac surgery with atriotomy. 7. Previous left atrial appendage closure/ligation. 8. Contraindications to systemic anticoagulation, catheter ablation, and/or general anaesthesia. 9. Pregnancy 10. Current enrolment in a study evaluating another device or drug.

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Pulmonary veins isolation + Cartofinder-guided ablation
The individualised mapping with Cartofinder intends to identify areas with the repetitive atrial activation patterns which are targeted with focal or linear ablation anchored on at least one end in an anatomical or electrical barrier.
• Pulmonary veins isolation
Wide area circumferential pulmonary veins isolation

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Royal Brompton & Harefield NHS Foundation Trust

Outcome
Type Measure Description Time frame Safety issue
Primary Freedom from atrial arrhythmia Freedom from any atrial arrhythmia without the use of antiarrhythmic drugs 12 monts
Secondary Freedom from atrial fibrillation Freedom from atrial fibrillation without the use of antiarrhythmic drugs 12 months
Secondary Atrial fibrillation burden reduction Reduction of the atrial fibrillation burden by 75% compared to baseline 12 months
Secondary Absolute atrial fibrillation burden Absolute atrial fibrillation burden after a single, first-time ablative procedure guided by individualised mapping vs. standard approach. 12 months
See also
  Status Clinical Trial Phase
Completed NCT05970120 - A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter N/A
Recruiting NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study N/A
Completed NCT03650556 - Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation N/A
Recruiting NCT04085731 - Driver-guided Ablation of Persistent Atrial Fibrillatiom
Withdrawn NCT02344394 - Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation N/A
Completed NCT01694563 - ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation N/A
Terminated NCT01683045 - Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats N/A
Active, not recruiting NCT03643224 - DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation N/A
Withdrawn NCT05093868 - Electrographic Flow Mapping Validation in Patients With Persistent Atrial Fibrillation (EVAL AF) N/A
Completed NCT05152966 - Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II) N/A
Completed NCT05043883 - Automated Assessment of PVI Using a Novel EP Recording System N/A
Completed NCT04022954 - HD Mapping of Atrial Fibrillation in Asia Pacific
Active, not recruiting NCT06124690 - Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas N/A
Completed NCT06260670 - FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation N/A
Not yet recruiting NCT05454111 - CARTO-Finder Guided Ablation Versus Multiscale Entropy Guided Ablation in Persistent Atrial Fibrillation N/A
Active, not recruiting NCT05077670 - Hybrid Characterization of Driver Sites During Atrial Fibrillation and Sinus Rhythm
Withdrawn NCT03835338 - WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm N/A
Completed NCT02275104 - Multimodal Image Processing Software to Guide Cardiac Ablation Therapy N/A
Not yet recruiting NCT05565183 - Combined Study of ATrial Strain and Voltage by High Density Mapping in Young Patients With Atrial Fibrillation. N/A
Completed NCT02274857 - Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures N/A